Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Team Effort Needed To Report On Science, University Of Alberta Study Says
Trust in science is diminishing, according to recent studies, especially in the area of biomedicine, biotech and genetics. University of Alberta researchers Tim Caulfield and Tania Bubela blame it on the complexity of many discoveries and they"re concerned the whole message from the study isn"t getting across to the general public.

Oregon Legislature Passes Statewide Health Reform Bills
The Oregon state legislature cleared two reform bills that passed its House of Representatives earlier this week, the Portland Oregonian reports. One bill will tax insurers and hospitals up to $500 million over two years to provide "health coverage for 80,000 uninsured children and an additional 35,000 uninsured low-income adults and put the state on a path toward covering all of its more than 600,000 uninsured residents." The state will leverage as much as $1 billion in federal matching funds. "Some of the federal money will be used to pay hospitals what they pay in taxes. Insurers also will get a portion of their tax money back," the Oregonian reports.
News of the day
Even While Considering Major Overhaul, Democrats Expand Government Role In Public Health
"As if hedging their bets on health reform, Democrats are emphasizing smaller but still significant health-related investments this year, from food safety and community health centers to a greater emphasis on rooting out abuses in Medicare and Medicaid," Politico reports. "It"s a far cry from the more ambitious government-backed insurance option proposed by President Barack Obama and House Democrats. But it does add up to a major expansion of the government"s role in public health - and one that shows a greater willingness to add personnel to regulate and administer programs."
Health Insurance

Covidien Announces Health Canada Approval For Its Generic Myocardial Perfusion Imaging Kit

Covidien (NYSE: COV), a leading global provider of healthcare products, announced that Health Canada has approved the Company"s Abbreviated New Drug Submission (ANDS) for its Kit for the Preparation of Technetium Tc 99m Sestamibi Injection. Covidien"s generic product is fully substitutable for Cardiolite®, a myocardial perfusion imaging agent used for detecting coronary artery disease. With Health Canada approval of the ANDS, which was filed by the Company"s Canadian subsidiary, Covidien"s generic product is expected to be available for customers in Canada this summer. The Company"s generic product also is available in the U.S., the U.K., Denmark, Germany and Puerto Rico. "We are pleased to receive approval in Canada and to introduce this generic diagnostic option to meet patients" needs," said Timothy R. Wright, President, Pharmaceutical Products and Imaging Solutions, Covidien. Covidien"s Imaging Solutions business is a leading provider of radiopharmaceuticals used in nuclear medicine imaging procedures. It also supplies contrast media delivery systems, which combine contrast media and power injectors, for Computed Tomography (CT), X-ray and Magnetic Resonance Imaging (MRI) procedures. Covidien


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009